Theratechnologies Inc (THTX)
1.21
-0.01
(-0.82%)
USD |
NASDAQ |
Nov 14, 16:00
1.21
0.00 (0.00%)
After-Hours: 18:23
Theratechnologies Profit Margin (Quarterly): 13.68% for Aug. 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 13.68% |
| May 31, 2024 | 4.48% |
| February 29, 2024 | -27.58% |
| November 30, 2023 | -11.75% |
| August 31, 2023 | -3.58% |
| May 31, 2023 | -57.06% |
| February 28, 2023 | -52.46% |
| November 30, 2022 | -37.02% |
| August 31, 2022 | -36.27% |
| May 31, 2022 | -118.0% |
| February 28, 2022 | -48.67% |
| November 30, 2021 | -52.79% |
| August 31, 2021 | -53.27% |
| May 31, 2021 | -35.94% |
| February 28, 2021 | -38.38% |
| November 30, 2020 | -29.02% |
| August 31, 2020 | -48.17% |
| May 31, 2020 | -33.83% |
| February 29, 2020 | -28.91% |
| November 30, 2019 | -39.36% |
| August 31, 2019 | -10.17% |
| May 31, 2019 | -20.33% |
| February 28, 2019 | -8.13% |
| November 30, 2018 | -7.03% |
| August 31, 2018 | 2.09% |
| Date | Value |
|---|---|
| May 31, 2018 | -19.92% |
| February 28, 2018 | -25.72% |
| November 30, 2017 | -32.81% |
| August 31, 2017 | -25.69% |
| May 31, 2017 | -90.94% |
| February 28, 2017 | -24.83% |
| November 30, 2016 | 1.72% |
| August 31, 2016 | 9.95% |
| May 31, 2016 | -5.52% |
| February 29, 2016 | -1.75% |
| November 30, 2015 | 5.42% |
| August 31, 2015 | 12.82% |
| May 31, 2015 | 11.24% |
| February 28, 2015 | -20.00% |
| November 30, 2014 | -132.9% |
| August 31, 2014 | -109.8K% |
| May 31, 2014 | 42.08% |
| February 28, 2014 | -211.4% |
| November 30, 2013 | -215.4% |
| August 31, 2013 | -88.88% |
| May 31, 2013 | -59.29% |
| February 28, 2013 | |
| November 30, 2012 | -111.3% |
| August 31, 2012 | -18.26% |
| May 31, 2012 | -53.35% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-118.0%
Minimum
May 2022
13.68%
Maximum
Aug 2024
-36.69%
Average
-36.64%
Median
Profit Margin (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 21.17% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -2.12K% |
| InMed Pharmaceuticals Inc | -151.0% |
| Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -4.56% |
| Return on Invested Capital | -9.93% |
| Gross Profit Margin (Quarterly) | 80.00% |
| Operating Margin (Quarterly) | 27.49% |
| Return on Net Operating Assets | -5.02% |